Navigation Links
CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer
Date:1/27/2010

e testing will provide the company with the required data regarding the performance of the QL Care Analyzer and the Troponin-I test, which will form the basis of the company's 510K application to the FDA.

In addition to opening the door for commencement of beta-site testing, the self-metering cartridge also gives CardioGenics the potential to selectively license its proprietary cartridge design to other POC device providers, which would provide CardioGenics with yet another revenue stream.

About CardioGenics Holdings Inc.

Through its CardioGenics subsidiaries, the Company develops technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's principal offices are located in Mississauga, Ontario, Canada.

Safe Harbor Statement - Certain statements made herein that are not historical are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 and may contain forward-looking statements, with words such as "Anticipate, "believe," "expect," "future," "may," "will," "should," "plan," "projected," "intend," and similar expressions to identify forward-looking statements. These statements are based on the Company's beliefs and the assumptions it made using information currently available to it. Because these statements reflect the Company's current views concerning future events, these statements involve risks, uncertainties and assumptions
'/>"/>

SOURCE CardioGenics Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive
2. CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads
3. CardioGenics Holdings Inc. Featured in Medical Device Daily
4. CardioGenics Holdings Inc. Announces Letter to Shareholders
5. CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
6. NeuIsys Announces Entrance into the Gastroenterology Market
7. WellWorld Science(R) Announces U.S. Launch of Livea(R),a Safe and Natural Appetite Control Supplement
8. Fuisz Pharma Announces Novel Anti Abuse System for Opiates
9. Perrigo Company Announces Quarterly Dividend
10. ETEX Corporation Announces Distribution Agreement With OrthoPediatrics Corp.
11. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ... to report its second quarter 2014 financial results on ... Dr. J. Joseph Kim and CFO ... a corporate update, and participate in a live Q&A ... for VGX-3100, Inovio,s immune therapy targeting pre-cancers and cancers ...
(Date:7/31/2014)... , Indien, August 1, 2014 ... BioQuiddity Inc. gaben heute bekannt, vor kurzem ... Anästhesieanwendungen zur Schmerzbehandlung nach chirurgischen Eingriffen eine ... Gebiet der Europäischen Union und weiterer europäischer ... versehene und mit Ropivacain gefüllte OneDose ReadyfusOR ...
(Date:7/31/2014)... Calif., July 31, 2014 IRIDEX Corporation (Nasdaq: ... quarter and six months ended June 28, 2014.  ... 2014, up 15% from $9.2 million in the 2013 second ... quarter of 2014. Revenues for the first six months of ... the first six months of last year. , Gross ...
Breaking Medicine Technology:Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 2Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 4IRIDEX Reports 2014 Second Quarter, Six-Month Results 5IRIDEX Reports 2014 Second Quarter, Six-Month Results 6IRIDEX Reports 2014 Second Quarter, Six-Month Results 7
... Nov. 14, 2011 Dynex Technologies, Inc., a ... testing easier, more cost-effective, and less labor intensive, ... sample processing system at the MEDICA 2011 – ... November 16 to 19, 2011. The Agility system ...
... Cheyenne Regional Medical Center is expanding its emergency ... AirLife Denver medical helicopter service in Cheyenne. ... and HCA-HealthONE, which operates AIRLIFE Denver. (Photo: ... and sonic green helicopter will be stationed in Cheyenne ...
Cached Medicine Technology:Dynex Technologies to Showcase Agility™ ELISA Processor at MEDICA 2011 - Hall 3, Stand D45-6 2Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONE's AirLife Denver 2Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONE's AirLife Denver 3
(Date:8/1/2014)... (PRWEB) August 01, 2014 Transparency ... announced the addition of a comprehensive report on ... ‘Infusion System Market (Large Volume, Disposable, Syringe, Ambulatory ... Growth, Trends And Forecast, 2013 – 2019’ is ... http://www.transparencymarketresearch.com . , To begin with, the ...
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, ... risk of heart attack and stroke, particularly if you work ... health officials reported Thursday. But being unemployed might be ... risk include job stress, exposure to air pollution -- like ... Dr. Sara Luckhaupt, from the National Institute for Occupational Safety ...
(Date:8/1/2014)... OR (PRWEB) August 01, 2014 In ... called hydrotherapy – was fundamental to the practice of ... water researcher Sharon Kleyne, water therapy has been relegated ... time when climate change, water shortages, drought and pollution ... diseases, the Sharon Kleyne Hour Power of Water host ...
(Date:8/1/2014)... August 01, 2014 According to the Suspension ... a bodybuilding program for men and women who want to ... of 191 suspension exercises and 27 intense workouts that help ... in its review that the Suspension Revolution 2.0 program provides ... how to create diet plans that help keep ...
(Date:8/1/2014)... Blindness is a reversible ailment these days . ... despite well-meaning efforts, still have a long way to go ... blindness that does not involve any kind of health risk ... takes the “slack” from the mainstream by providing a cure ... , Alternative health specialist Kevin Richardson actually has the ...
Breaking Medicine News(10 mins):Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 3Health News:Some Jobs Harder on the Heart Than Others, Report Finds 2Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 2Health News:Water Researcher Advocates Reevaluation of 18th and 19th Century Water Therapy Movement 3Health News:Suspension Revolution 2.0 PDF Review Exposes Dan Long's Program For Building Muscle – Vkool.com 2Health News:Suspension Revolution 2.0 PDF Review Exposes Dan Long's Program For Building Muscle – Vkool.com 3Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2
... been found by researchers to be more effective than ... borderline personality disorder. This study , which included 38 ... ages of 19 and 51 was conducted by researchers ... differences in rapid mood shift, impulsivity and aggression when ...
... that HRT could reduce risk of heart attack in post ... 1000 women of ages 50 to 69 conducted by the ... study was to determine whether a combination// of oestrogen and ... menopausal women who had already sufferd a previous attack. ...
... observe why surgery may trigger cognitive problems in some ... some older people develop problems with memory and other mental ... Operative Cognitive Dysfunction (POCD).Often relatives will say that the person ... It was assumed, at first, that the anaesthetic was to ...
... skills do home care which is advantageous for ... or chronic obstructive pulmonary disease (COPD) - can be ... A new study from researchers at Barcelona// Hospital, Spain, ... care in the home setting cuts costs, re-admission to ...
... researchers suggests that nurses and junior doctors can both carry ... competence.,There's a shortage of junior doctors in the UK// and ... to take over some of their roles. Researchers in Ireland, ... nurses assess people before surgery. ,They found that ...
... a recent survey, it has been observed that there are ... fasciitis is an inflammation of the band of fibrous tissue ... and the heel.// It causes excruciating pain first thing in ... eases off once you have been on the move for ...
Cached Medicine News:
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
... up kit. Includes configured Laptop PC with ... 1 MultiBlock satellite thermal Cycler (non-robotic). ... friendly software. Store/track run data. ... Outstanding uniformity. Advanced control algorithms ...
PxE thermal Cycler. 0.5ml block holds 48 0.5 ml tubes or 96 0.3 ml tubes. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User frien...
PxE thermal Cycler. 0.2ml, 96 well block holds 96 tubes or 1 x 96 well plate. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced reaction times. User f...
Medicine Products: